Article: GlaxoSmithKline and Boehringer Ingelheim Agree to Assess the Development of Important HIV Medicines for the Developing World.

Article: GSK, BI agree generics for South Africa.(GlaxoSmithKline ...
Pharma Marketletter;  December 15, 2003 ;     700+ words ...GlaxoSmithKline and Boehringer Ingelheim have stated that they will ... manufacture of nevirapine, while GSK has said that it will grant ... manufacturer. In addition, GSK said in a statement that it ... reportedly said it will not penalize GSK for anti-competitive behavior ...

Article: GSK and BI to seek only 5% royalty rate on South African ...
Pharma Marketletter;  December 22, 2003 ;     700+ words ... ... sacrifices which GlaxoSmithKline and Boehringer Ingelheim will make in agreeing to license ... the royalty fee requested by GSK was 30% and for BI it was ... lower." Under the accord, GSK will grant licenses to four ... sectors; before the agreement, GSK and BI had granted a license ...

Article: GSK and BI license SA's Thembalami to make ...
Pharma Marketletter;  July 19, 2004 ;     700+ words ... ... been licensed by European drug majors GlaxoSmithKline and Boehringer Ingelheim to make and sell generic antiretroviral drugs for the treatment ... sub-Saharan Africa, according to local media reports. GSK told the Panafrican News Agency that the measure is intended ...

Article: Drug Companies Close Booths, Flee Handful of AHF AIDS Advocates ...
PR Newswire;  July 13, 2004 ;     700+ words ... ... pharmaceutical companies -- Gilead and Boehringer Ingelheim -- kept their booths open ... acknowledge and thank both Boehringer Ingelheim and Gilead for being willing ... the other drug companies -- GSK, BMS, Merck and Roche ...

Article: BI and GSK to co-package HIV drugs.(Boehringer ...
Pharma Marketletter;  July 19, 2004 ;     645 words ...Germany's Boehringer Ingelheim and UK drug major GlaxoSmithKline have signed a letter of intent for an accelerated development program for a co-package of Viramune ...

Article: BI and GSK to co-package HIV drugs.(Boehringer ...
Pharma Marketletter;  July 19, 2004 ;     700+ words ...Germany's Boehringer Ingelheim and UK drug major GlaxoSmithKline have signed a letter of intent for an accelerated development program for a co-package of Viramune ...

Article: Boehringer Ingelheim and GlaxoSmithKline to Develop ...
PR Newswire;  July 12, 2004 ;     700+ words ... ... PRNewswire/ -- Boehringer Ingelheim and GlaxoSmithKline plc (GSK) announced today ... developing world, Boehringer Ingelheim and GSK support efforts to ... living with HIV. Boehringer Ingelheim and GSK have initiated contact ...